Both in Biotechnology
Vor Biopharma vs Prime Medicine
Over the past year VOR returned −18.0% and PRME returned +15.4%; their daily moves had a correlation of 0.24.
VOR −18.0% PRME +15.4%Growth of $1, one year, split-adjusted
| Metric | VOR | PRME |
|---|---|---|
| Price | $20.91 | $5.24 |
| Market cap | $1.24B | $950.4M |
| Today | +1.26% | −2.24% |
| 1 month | +9.6% | +71.5% |
| 6 months | +45.9% | +47.8% |
| Year to date | +59.9% | +51.0% |
| 1 year | −22.3% | +8.7% |
| Revenue growth (YoY) | — | +3.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −3649.0% |
| P/E (TTM) | 2.0× | — |
| Price / sales | — | 233.3× |
| Net cash | $466.1M | $95.1M |
| Dividend yield | — | — |
| Volatility (60d) | 59.0% | 109.1% |
| Short % of float | 17.6% | 34.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).